Section 657.23.13. Labeling drugs under special circumstances.  


Latest version.
  •          23.13(1) Insulin, ophthalmics, otic preparations, biologicals, and other injectables for individual patients. These drugs shall be dispensed with a label affixed to the immediate container showing at least the resident’s name and location.

             23.13(2) Legend solutions—irrigation and infusion. Legend irrigation solutions and infusion solutions supplied by a licensed pharmacy may be stored in the locked medication area of a long-term care facility provided that:

                a.               The facility uses the solution only within the confines of the facility and under the orders of an authorized prescriber;

                b.               Upon use, the container is identified by resident name and is used exclusively for that resident;

                c.               The container is dated and initialed upon opening;

                d.               The solution is stored appropriately after opening according to facility policy.

             23.13(3) Floor-stocked, nonprescription drug containers. All such nonprescription drugs intended for use within the facility shall be in appropriate containers and adequately labeled to identify, at a minimum, brand name or generic name and manufacturer, strength, lot number, and expiration date. An internal code that centrally references manufacturer and lot number may be utilized.

             23.13(4) Leave meds. Labeling of prescription drugs for residents on leave from the facility for a period in excess of 24 hours shall comply with 657—subrule 6.10(1). The dispensing pharmacist shall be responsible for packaging and labeling leave meds in compliance with this subrule.

             23.13(5) Discharge meds. Drugs authorized for a resident being discharged from the facility shall be labeled in compliance with 657—subrule 6.10(1) before the resident removes those drugs from the facility premises. The dispensing pharmacist shall be responsible for packaging and labeling discharge meds in compliance with this subrule.

    [ARC 1961C, IAB 4/15/15, effective 5/20/15]